Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PANCHO: p53-Adjusted Neoadjuvant Chemotherapy for Esophageal Cancer
NCT00525200Phase 3Completed
- Start
- Jun 2007
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel in esophageal cancer. Started Jun 2007; status: completed.
02
Drugs
docetaxel
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT00525200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00525200.